Pelthos Therapeutics Inc.
Total Trades
1
Buys
0
Sells
1
Largest Trade
$100K–$500K
Insiders
1
Institutional Funds
9
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Friedberg Ezra M | Director | SELL | $100K–$500K | 10K | $28.03 | Nov 26, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 9 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Ikarian Capital, LLC | 256K | $1M+ | SH |
| J. Goldman & Co LP | 78K | $1M+ | SH |
| VANGUARD GROUP INC | 65K | $1M+ | SH |
| CANTOR FITZGERALD, L. P. | 35K | $1M+ | SH |
| Knott David M Jr | 19K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 11K | $100K–$500K | SH |
| Pale Fire Capital SE | 8K | $100K–$500K | SH |
| Steward Partners Investment Advisory, LLC | 2K | $50K–$100K | SH |
| UBS Group AG | 434 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
8.4%
256K shares
SC 13G/A · Feb 5, 2026
9.9%
319K shares
SC 13G/A · Nov 14, 2025
6.1%
186K shares
SC 13G · Nov 14, 2025
9.1%
280K shares
Ligand Pharmaceuticals Incorporated
SC 13D/A · Nov 10, 2025
49.9%
5.2M shares
SC 13G/A · Aug 13, 2025
0.0%
0 shares
SC 13G · Jul 8, 2025
9.9%
303K shares
SC 13D/A · Jul 4, 2025
8.3%
250K shares
Ligand Pharmaceuticals Incorporated
SC 13D · Jul 3, 2025
49.9%
4.9M shares
SC 13G · Feb 14, 2025
7.3%
441K shares
SC 13G · Jan 15, 2025
9.5%
574K shares
SC 13G/A · Nov 13, 2024
5.0%
301K shares
SC 13G · Mar 4, 2024
8.2%
472K shares
SC 13G · Mar 1, 2024
6.7%
384K shares
Aperture Healthcare Ventures Ltd.
SC 13G · Mar 1, 2024
7.7%
444K shares
SC 13G · Mar 1, 2024
6.4%
369K shares
SC 13G · Mar 1, 2024
8.4%
483K shares
SC 13G · Mar 1, 2024
5.5%
319K shares
SC 13D · Feb 26, 2024
9.5%
546K shares